Increased Susceptibility to Vancomycin-Resistant Enterococcus Intestinal Colonization Persists after Completion of Anti-Anaerobic Antibiotic Treatment in Mice

Infection Control and Hospital Epidemiology

Volumn 25, Issue 5, 2004, Pages 373-379

  Stiefel, Usha ^a   Pultz, Nicole J ^b   Helfand, Marion S ^b   Donskey, Curtis J ^b  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CEFEPIME; CEFOXITIN; CLINDAMYCIN; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; SODIUM CHLORIDE; VANCOMYCIN;

ANAEROBIC BACTERIUM; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; CONTROLLED STUDY; CONVALESCENCE; DENATURING GRADIENT GEL ELECTROPHORESIS; DRUG SENSITIVITY; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; FEMALE; INOCULATION; INTESTINE FLORA; MOUSE; NONHUMAN;

ANIMALS; ANTI-BACTERIAL AGENTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENTEROCOCCUS; FEMALE; INTESTINES; KLEBSIELLA PNEUMONIAE; MICE; VANCOMYCIN RESISTANCE;

EID: 2442597125     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502408     Document Type: Article

References (31)

1. Donskey CJ, Hanrahan JA, Hutton RA, Rice LB. Effect of parental antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis 1999;180:384-390.
2. Donskey CJ, Hanrahan JA, Hutton RA, Rice LB. Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. J Infect Dis 2000;181:1830-1833.
3. Donskey, CJ, Chowdhry TK, Hecker MT, et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000;343:1925-1932.
4. Donskey CF, Hoyen CK, Das SM, Farmer S, Dery M, Bonomo RA. Effect of oral Bacillus coagulans administration on density and persistence of colonization with vancomycin-resistant enterococci in the mouse gastrointestinal tract. Lett Appl Microbiol 2001;33:84-88.
5. Donskey CJ, Hoyen CK, Das SM, Helfand MS, Hecker MT. Racurrence of vancomycin-resistant Enterococcus stool colonization during antibiotic therapy. Infect Control Hosp Epidemiol 2002;23:436-440.
6. Baden LR, Critchley IA, Sahm DF, et al. Molecular characterization of vancomycin-resistant enterococci repopulating the gastrointestinal tract following treatment with a novel glycolipodepsipeptide, ramoplanin. J Clin Microbiol 2002;40:1160-1163.
7. Finegold SM, Mathisen GE, George WL. Changes in human intestinal flora related to the administration of antimicrobial agents. In: Hentges D, ed. Human Intestinal Microflora in Health and Disease. New York: Academic Press; 1983:355-446.
8. Vollaard EJ, Clasener HAL. Colonization resistance. Antimicrob Agents Chemother 1994;38:409-414.
9. Nord CE, Heimdahl A, Kager L, Malmborg AS. The impact of different antimicrobial agents on the normal gastrointestinal microflora of humans. Rev Infect Dis 1984;6(suppl 1):S270-S275.
10. Mulligan ME, Citron D, Gabay E, Kirby BD, Georgi WL. Finegold SM. Alterations in human fecal flora, including ingrowth of Clostridium difficile, related to cefoxitin therapy. Antimicrob Agents Chemother 1984;26:343-346.
11. Kager L, Liljeqvist L, Malmborg AS, Nord CE. Effect of clindamycin prophylaxis on the colonic microflora in patients undergoing colorectal surgery. Antimicrob Agents Chemother 1981;20:736-740.
12. Nord CE, Brismar B, Hasholm-Tengve B, Tunevall G. Effect of piperacillin/tazobactam therapy on intestinal microflora. Scand J Infect Dis 1992;24:209-213.
13. Bacher K, Schaeffer M, Lode H, Nord CE, Borner K, Koeppe P. Multiple dose pharmacokinetics, safety, and effects on faecal microflora, of cefepime in healthy volunteers. J Antimicrob Chemother 1992;30:365-375.
14. Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey and man. Cancer Chemotherapy Reports 1966;50:219-244.
15. Donskey CJ, Hujer A, Das SM, Pultz NJ, Bonomo RA, Rice LB. Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients. J Microbiol Methods 2003;54:249-256.
16. Quale J, Landman D, Saurina G, Atwood E, DiTiore V, Patel K. Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci. Clin Infect Dis 1996;23:1020-1025.
17. Bradley SJ, Wilson ALT, Allen MC, Sher HA, Goldstone AH, Scott GM. The control of hyperendemic glycopeptide-resistant Exterococcus species on a haematology unit by changing antibiotic usage. J Antimicrob Chemother 1999;43:261-266.
18. May AK, Melton SM, McGwin G, Cross JM, Moser SA, Rue LW. Reduction of vancomycin-resistant enterococcal infections by limitation of broad-spectrum cephalosporin use in a trauma and burn intensive care unit. Shock 2000;14:259-264.
19. Donskey CJ, Schreiber JR, Jacobs MR, et al. A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in Northeast Ohio. Clin Infect Dis 1999;29:573-579.
20. Maraki S, Barbounakis E, Chatzinikolaou I, et al. Effects of cefepime, cefixime, and ceftibuten on murine gut colonization by Candida albicans. Chemotherapy 1998;44:405-408.
21. Hoyen CK, Pultz NJ, Paterson DL, Aron DC, Donskey CJ. Effect of parenteral antibiotic administration on the establishment of intestinal colonization with extended-spectrum β-lactamase-producing Klebsiella pneumoniae in mice. Antimicrob Agents Chemother 2003;47:3610-3612.
22. Patterson JE, Hardin TC, Kelly CA, Garcia RC, Jorgenson JH. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2000;21:455-458.
23. Bhalla A, Pultz NJ, Ray AJ, Hoyen CK, Eckstein EC, Donskey CJ. Antianaerobic antibiotic therapy promotes overgrowth of antibiotic-resistant, gram-negative bacilli and vancomycin-resistant enterococci in the stool of colonized patients. Infect Control Hosp Epidemiol 2003;24:644-649.
24. Paterson DL, Ndirangu M, Clarke L, Bandlamuri S, Donskey CJ. Relative "collateral damage" caused by piperacillin/tazobactam and cefepime in patients treated in the intensive care unit. Presented at the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy; September 14-17, 2003; Washington, DC. Abstract K-1418.
25. Thomas C, Golledge CL, Riley TV. Ciprofloxacin and Clostridium difficile-associated diarrhea. Infect Control Hosp Epidemiol 2002;23:637-638.
26. Wistrom J, Norrby SR, Myhre EB, et al. Frequency of antibiotic-associated diarrhoea in 2,462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 2001;47:43-50.
27. Edlund C, Nord CE. Effect of quinolones on intestinal ecology. Drugs 1999;58 (suppl 2):65-70.
28. Harbarth S, Cosgrove S, Carmeli Y. Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci. Antimicrob Agents Chemother 2002;46:1619-1628.
29. Donskey CJ, Helfand MS, Pultz NJ, Rice LB. Effect of parenteral fluoroquinolone administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract. Antimicrob Agents Chemother 2004;48:326-328.
30. Hecker MT, Aron DC, Patel NP, Lehman MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 2003;163:972-978.
31. Stiefel U, Pultz NJ, Harmoinen J, Koski P, Lindevall K, Donskey CJ. Oral administration of recombinant β-lactamase prevents piperacillin-induced overgrowth of nosocomial pathogens in the intestinal tract of mice. J Infect Dis 2003;188:1605-1609.